Insider Transactions in Q1 2021 at Boston Scientific Corp (BSX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 10
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Grant, award, or other acquisition
|
Direct |
7,197
+6.47%
|
-
|
|
Feb 10
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
8,881
-3.56%
|
$337,478
$38.85 P/Share
|
|
Feb 10
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Grant, award, or other acquisition
|
Direct |
17,995
+6.72%
|
-
|
|
Feb 08
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Bona fide gift
|
Indirect |
1,520
+20.11%
|
-
|
|
Feb 08
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Bona fide gift
|
Direct |
3,040
-1.3%
|
-
|
|
Feb 08
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Open market or private sale
|
Direct |
16,902
-37.54%
|
$659,178
$39.39 P/Share
|
|
Feb 08
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
9,000
+16.66%
|
$117,000
$13.08 P/Share
|
|
Feb 04
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Open market or private sale
|
Direct |
11,317
-84.62%
|
$430,046
$38.0 P/Share
|
|
Feb 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
919
-3.34%
|
$32,165
$35.95 P/Share
|
|
Feb 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,130
+10.23%
|
-
|
|
Jan 05
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Open market or private sale
|
Direct |
17,083
-6.09%
|
$597,905
$35.32 P/Share
|
|
Jan 05
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Open market or private sale
|
Direct |
8,108
-5.8%
|
$283,780
$35.31 P/Share
|
|
Jan 04
2021
|
Scott Olson SVP & Pres, CRM, Diagnostics |
SELL
Open market or private sale
|
Direct |
700
-5.89%
|
$25,200
$36.08 P/Share
|
|
Jan 01
2021
|
Daniel J. Brennan EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
7,396
-2.57%
|
$258,860
$35.95 P/Share
|
|
Jan 01
2021
|
Daniel J. Brennan EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,479
+7.84%
|
-
|
|
Jan 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
SELL
Payment of exercise price or tax liability
|
Direct |
4,758
-11.67%
|
$166,530
$35.95 P/Share
|
|
Jan 01
2021
|
Arthur C Butcher EVP& Grp Pres, MedSurg & APAC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,879
+21.06%
|
-
|
|
Jan 01
2021
|
Wendy Carruthers EVP, Human Resources |
SELL
Payment of exercise price or tax liability
|
Direct |
3,085
-1.66%
|
$107,975
$35.95 P/Share
|
|
Jan 01
2021
|
Wendy Carruthers EVP, Human Resources |
BUY
Exercise of conversion of derivative security
|
Direct |
9,791
+5.0%
|
-
|
|
Jan 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
SELL
Payment of exercise price or tax liability
|
Direct |
1,809
-11.49%
|
$63,315
$35.95 P/Share
|
|
Jan 01
2021
|
Jodi Euerle Eddy SVP, Chief Info & Digital Off. |
BUY
Exercise of conversion of derivative security
|
Direct |
5,439
+25.68%
|
-
|
|
Jan 01
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
SELL
Payment of exercise price or tax liability
|
Direct |
13,619
-5.49%
|
$476,665
$35.95 P/Share
|
|
Jan 01
2021
|
Joseph Michael Fitzgerald EVP & Group Pres, Cardiology |
BUY
Exercise of conversion of derivative security
|
Direct |
27,199
+9.87%
|
-
|
|
Jan 01
2021
|
Edward F Mackey EVP, Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
5,001
-6.1%
|
$175,035
$35.95 P/Share
|
|
Jan 01
2021
|
Edward F Mackey EVP, Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
16,318
+16.59%
|
-
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
44,291
-2.14%
|
$1,550,185
$35.95 P/Share
|
|
Jan 01
2021
|
Michael F Mahoney Chairman, President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
108,797
+5.0%
|
-
|
|
Jan 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-8.03%
|
$74,445
$35.95 P/Share
|
|
Jan 01
2021
|
Ian T Meredith EVP Global Chief Med Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,527
+19.78%
|
-
|
|
Jan 01
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
SELL
Payment of exercise price or tax liability
|
Direct |
3,859
-2.69%
|
$135,065
$35.95 P/Share
|
|
Jan 01
2021
|
Jeffrey B. Mirviss EVP&Pres, Periph Intervent |
BUY
Exercise of conversion of derivative security
|
Direct |
11,967
+7.69%
|
-
|
|
Jan 01
2021
|
David A Pierce EVP Pres MedSurg |
SELL
Payment of exercise price or tax liability
|
Direct |
5,001
-29.45%
|
$175,035
$35.95 P/Share
|
|
Jan 01
2021
|
David A Pierce EVP Pres MedSurg |
BUY
Exercise of conversion of derivative security
|
Direct |
16,318
+49.01%
|
-
|
|
Jan 01
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
SELL
Payment of exercise price or tax liability
|
Direct |
3,625
-1.52%
|
$126,875
$35.95 P/Share
|
|
Jan 01
2021
|
Maulik Nanavaty SVP & Pres, Neuromodulation |
BUY
Exercise of conversion of derivative security
|
Direct |
9,791
+3.94%
|
-
|
|
Jan 01
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
2,127
-8.16%
|
$74,445
$35.95 P/Share
|
|
Jan 01
2021
|
Desiree Ralls Morrison SVP, GC and Corp Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,527
+20.03%
|
-
|
|
Jan 01
2021
|
John Bradley Sorenson EVP, Global Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
2,360
-5.22%
|
$82,600
$35.95 P/Share
|
|
Jan 01
2021
|
John Bradley Sorenson EVP, Global Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
7,071
+13.52%
|
-
|
|
Jan 01
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
SELL
Payment of exercise price or tax liability
|
Direct |
5,891
-5.74%
|
$206,185
$35.95 P/Share
|
|
Jan 01
2021
|
Eric Francis Yves Thepaut EVP & Pres, Eur, Mid-East, Afr |
BUY
Exercise of conversion of derivative security
|
Direct |
10,879
+9.58%
|
-
|